Scilex Holding Company announces exclusive product distribution agreement with CH Trading Group LLC to commercialise ZTlido across certain designated territories including Middle East and North Africa
Scilex Holding Company announced the signing of a Product Distribution Agreement (“Agreement”) for certain designated territories with CH Trading Group LLC (“CH Trading”), an international import, export and trading company focused on the Middle East and North Africa (MENA) Region and other markets, to distribute Scilex’s lead non-opioid commercial pain management product, ZTlido. Scilex is a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc.